Garret Jérôme, Harly Edouard, Le Huec Jean-Charles, Brunner Ulrich, Rotini Roberto, Godenèche Arnaud
Clinique du Parc, Lyon, France.
Orthopédie-Traumatologie Department, Hôpital Pellegrin, Bordeaux, France.
JSES Open Access. 2018 Dec 24;3(1):37-42. doi: 10.1016/j.jses.2018.09.002. eCollection 2019 Mar.
In patients with osteoarthritis (OA) and an intact rotator cuff, hemi-shoulder arthroplasty (HSA) can be a viable option as it offers the advantage of keeping the native glenoid intact. However, glenoid erosion has frequently been reported. The aim of this study was to report preliminary clinical results of HSA with a new pyrolytic carbon (pyrocarbon) humeral head.
This prospective multicenter study included a continuous series of 65 patients who underwent pyrocarbon HSA in 5 centers.
At the time of analysis, 1 patient was lost to follow-up, 3 patients underwent revision, and 61 patients were evaluated at a mean follow-up of 25.9 ± 3.3 months. The mean age at index surgery was 57.9 ± 13.3 years. The indications were primary glenohumeral OA in 37 patients, osteonecrosis in 11, secondary OA in 11, and rheumatoid arthritis in 2. The mean Constant score increased from 31.0 ± 15.8 points at baseline to 74.6 ± 17 points at last follow-up. Radiographic analyses showed that 86% of glenoids remained unchanged whereas 14% evolved slightly.
Pyrocarbon HSA grants improvement in pain and function in patients with primary OA or secondary OA after instability but at a lower level in patients with post-traumatic sequelae (secondary OA or osteonecrosis). These preliminary clinical and radiologic results are encouraging, although they need to be confirmed by longer-term follow-up observations.
在患有骨关节炎(OA)且肩袖完整的患者中,半肩关节置换术(HSA)可能是一种可行的选择,因为它具有保留天然关节盂完整的优势。然而,关节盂侵蚀的情况屡有报道。本研究的目的是报告采用新型热解碳(热解炭)肱骨头的HSA的初步临床结果。
这项前瞻性多中心研究纳入了在5个中心连续接受热解碳HSA的65例患者。
在分析时,1例患者失访,3例患者接受了翻修手术,61例患者接受了评估,平均随访时间为25.9±3.3个月。初次手术时的平均年龄为57.9±13.3岁。适应证包括原发性盂肱关节OA 37例、骨坏死11例、继发性OA 11例、类风湿关节炎2例。Constant评分的平均值从基线时的31.0±15.8分增加到最后随访时的74.6±17分。影像学分析显示,86%的关节盂保持不变,而14%有轻微进展。
热解碳HSA可改善原发性OA或不稳定后继发性OA患者的疼痛和功能,但对于创伤后后遗症(继发性OA或骨坏死)患者改善程度较低。这些初步的临床和影像学结果令人鼓舞,尽管需要通过长期随访观察来证实。